These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18802167)

  • 1. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
    Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
    J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
    Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
    Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
    Hawfield A; Lovato J; Covington D; Kimmick G
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
    Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
    J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
    Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike.
    Barton MK
    CA Cancer J Clin; 2012; 62(5):279-80. PubMed ID: 22847502
    [No Abstract]   [Full Text] [Related]  

  • 9. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
    Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
    Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
    Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
    Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of older people with non-small cell lung cancer in England.
    Beckett P; Callister M; Tata LJ; Harrison R; Peake MD; Stanley R; Woolhouse I; Slade M; Hubbard RB
    Thorax; 2012 Sep; 67(9):836-9. PubMed ID: 22771514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment for elderly patients with colon cancer. An observational study.
    Pasetto LM; Falci C; Basso U; Gasparini G; D'Andrea M; Bonginelli P; Bajetta E; Platania M; Alabiso O; Miraglia S; Bertona E; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Negru ME; Luchena G; Giordano M; Buzzi F; Ricottao R; Sienao S; Monfardini S
    Anticancer Res; 2008; 28(4C):2513-8. PubMed ID: 18751443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of older age on the efficacy of newer adjuvant chemotherapy regimens in colon cancer, a subgroup analysis of a meta-analysis: Practice changing? Certainly not; Hypothesis generating? Perhaps.
    Copur MS
    Clin Colorectal Cancer; 2009 Oct; 8(4):190-1. PubMed ID: 19822507
    [No Abstract]   [Full Text] [Related]  

  • 17. Does reimbursement influence chemotherapy treatment for cancer patients?
    Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
    Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the adjuvant treatment of colorectal cancer.
    Nordman IC; Iyer S; Joshua AM; Clarke SJ
    ANZ J Surg; 2006 May; 76(5):373-80. PubMed ID: 16768699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Completion of therapy by Medicare patients with stage III colon cancer.
    Gibbs P; McLaughlin S; Skinner I; Jones I; Hayes I; Chapman M; Johns J; Lim L; Faragher I
    J Natl Cancer Inst; 2006 Nov; 98(21):1582. PubMed ID: 17077360
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant therapy for colon cancer: present and perspectives.
    De Dosso S; Sessa C; Saletti P
    Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.